Statement by a Working Group conceived by the Polish National Consultants in Cardiology and Neurology addressing the use of implantable cardiac monitors in patients after ischaemic embolic stroke of undetermined sourceMichał M. Farkowski, Maciej Sterliński, Michał Karliński et al.|Neurologia i Neurochirurgia Polska|2018Cited by 9
Wearable cardioverter-defibrillator use in clinical settings in Poland: Nationwide observational cohort studyMaciej Sterliński, Jerzy Krzysztof Wranicz, Andrzej Przybylski et al.|Kardiologia Polska|2025Cited by 5
Hospitalization and interventional procedures in cardiology departments covering a region with 2.5 million inhabitants during the SARS-CoV-2 pandemicJarosław Dróżdż, Jarosław D. Kasprzak, Grzegorz Piotrowski et al.|Kardiologia Polska|2021Cited by 3
Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarctionPrzemysław Mitkowski, Dominik Golicki, Maciej Sterliński et al.|Kardiologia Polska|2025Cited by 1
MON-P043: Activation of the Immune System in Patients Receiving Long-Term Parenteral Nutrition (PN)Sylwia Osowska, Marek Radkowski, A. Pawetczyk et al.|Clinical Nutrition|2016Cited by 0